Qiagen clears GI panels for QiaStat‑Dx Rise — hour‑long syndromic testing

Qiagen won FDA clearance to run its QiaStat‑Dx Gastrointestinal Panels on the high‑throughput QiaStat‑Dx Rise platform, enabling combined respiratory and GI syndromic testing on a single automated system. The cleared panel detects 16 bacterial, viral and parasitic pathogens — including key STEC subtypes — with results in about one hour and minimal hands‑on time. The Rise platform’s ability to deliver cycle threshold values and amplification curves adds diagnostic context for co‑infections. Labs and hospital systems gain a unified, rapid option for multiplex pathogen detection that can streamline throughput and outbreak response.